Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Acorda Therapeutics Inc (NASDAQ:ACOR)

Delayed Data
As of Jan 19
 0.00 / 0.00%
Today’s Change
Today|||52-Week Range
M&A Rumors Rise Again
Jan 19 / TheStreet.com - Paid Partner Content
Acorda's Shares Down on Disappointing Ampyra View for 2018
Jan 09 / Zacks.com - Paid Partner Content
Biotech Stock Roundup: Celgene to Acquire Impact, J.P. Morgan Healthcare Conference i...
Jan 10 / Zacks.com - Paid Partner Content